Deutsche Bank initiated coverage of Circassia Group with a Hold rating and 250 GBp price target. The analyst says the company specializes in the manufacture of vectors to deliver genetic material using a range of viruses to enhance the disease-fighting capabilities of donor or patient’s cells.
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CSSPF: